|
|
Kevin Landells |
|
|
|
Vice President, Business Head for IRT |
IQVIA Technologies |
https://proventainternational.com/wp-content/uploads/2023/08/Kevin-Landells.jpg |
Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning operations, project management, client partnerships and Business transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
|
|
|
Tim Riely |
|
|
|
Vice President, Clinical Data & Analytics |
IQVIA |
https://proventainternational.com/wp-content/uploads/2023/08/Tim-Riely-1.jpg |
Tim has 20 years of experience delivering business intelligence, data management and analytical solutions in both leadership and consulting roles. Tim currently leads the IQIVA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs. As head of CDAS, Tim is responsible for full lifecycle delivery of R&D data and visualizations solutions for clinical operations, clinical data management, and analytics-as-service products. Tim’s background includes a unique combination of payer, provider, and clinical research technology experience. |
|
|
KK |
|
Rumrill |
|
Senior Director, Site Suite |
IQVIA Technologies |
https://proventainternational.com/wp-content/uploads/2024/02/KK-Rumrill.jpg |
KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform. |
|
|
Jim |
|
DiCesare |
|
Vice President, Financial Management Solutions |
IQVIA Technologies |
https://proventainternational.com/wp-content/uploads/2024/02/James-DiCesare.jpg |
Jim DiCesare is passionate about delivering innovative Cost Benchmarking, CTA Negotiation and Site Payment services that support clinical research conducted by sponsors and CROs. With over 25 years of industry experience leading clinical operations teams at Merck, DrugDev, and now IQVIA Technologies, Jim has expertise across the contracting, budgeting, and investigator grant payment management continuum. He is a frequent speaker at industry conferences and has written for a variety of publications. He has a B.S. in Accounting from Kutztown University. |
|
|
Ann |
|
Dokus |
|
Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials |
IQVIA |
https://proventainternational.com/wp-content/uploads/2022/12/Ann-Dokus.jpg |
Ann Dokus is the Senior Director of Experience Optimization in the Patient and Site Centric Solutions organization. An industry veteran of with over 30 years experience in Pharmaceutical R&D, Medical Devices, Information Technology and Clinical Research, Ann’s journey has spanned start ups, Fortune 100 companies and ultimately a role at IQVIA.
Ann is a passionate advocate for Patients, firmly believing in delivering clinical research opportunities to the community. She has spearheaded technology initiatives in Identity and Access Management, Clinical Trial Matching, Patient Recruitment, Medical Records Retrieval and is now excited about the power of Artificial Intelligence to deliver accessibility to trials. A firm believer in meeting the patients where they are, Ann’s focus at IQVIA is supporting sponsors and sites in delivering the promise of the “last mile” … enrolled, supported and sustained patient engagement while optimizing the patient experience throughout the journey. |
|
|
Murray |
|
Aitken |
|
Executive Director, Senior Vice President |
IQVIA Institute for Human Data Science, IQVIA |
https://proventainternational.com/wp-content/uploads/2024/02/Murray-Aitken.jpg |
As head of the IQVIA Institute for Human Data Science, Murray Aitken provides policy setters and decision-makers in the global health sector with evidence, analysis, and insights that contribute to the advancement of Human Data Science to improve human health outcomes. Aitken is tasked with creating and managing a research agenda that leaders in global governments, payers, providers, academia, and the life sciences industry use to accelerate the understanding of global trends in disease patterns, data science, and technology. This research is used to foster innovation critical to evidence-based decision-making and the advancement of human health. |
|
|
Jane |
|
Twitchen |
|
Executive Director, Head, Clinical Trial Accelerator Unit |
Biogen |
https://proventainternational.com/wp-content/uploads/2022/03/Jane-Twitchen.jpg |
Jane Twitchen graduated with a BSc in Medical Physics from the University of Exeter, UK and commenced her career with Covance, supporting a number of trials investigating radioisotope image optimisation. Having developed a keen interest in processes and systems, she then joined SAS, where she worked in the Alliances team collaborating with partners such as PWC, McKinsey and Accenture to define and implement solutions for pharmaceutical clients. During her tenure with SAS, Jane was also sponsored to complete her MBA. She proceeded to a number of software and service providers prior to joining Biogen in 2013, initially joining the Global Regulatory Affairs Quality and Operations team and moving to Global Clinical Operations in 2015. In her current role, Jane is Executive Director, Head of Biogen’s Clinical Trial Accelerator Unit and is responsible for delivery of Biogen’s goals for accelerated study start-up cycle time, in addition to embedding innovative operational delivery through the use of technology. |
|
|
Zabir |
|
Macci |
|
Director, eCOA Business Strategy |
IQVIA |
https://proventainternational.com/wp-content/uploads/2020/10/Zabir-Macci_2019-sm.jpg |
Zabir brings over 15 years of learning across risk-based and centralized monitoring, eCOA, business analysis, clinical technologies, process improvement, and analytics for clinical trials. He is part of IQVIA’s DP&S (Digital Products and Solutions) team involved in the development and execution of business strategies working closely with the cross-functional leadership teams to influence strategic priorities and ensure it exceeds customer expectations and market demands. He holds a Bachelor of Engineering degree in Computer Science from India and has an MBA in Management and Marketing from Texas Tech University. |
|
|
Rick |
|
O’Hara |
|
Director, Clinical Outsourcing |
OncoC4 |
https://proventainternational.com/wp-content/uploads/2024/04/Rick-OHara.jpg |
Rick O’Hara has been working in the R&D/Clinical business operations arena for over 25 years. Operating in all facets of outsourcing at OncoC4, Endo and Johnson and Johnson. He holds a BS and an MBA from St. Josehp’s University in Philadelphia |
|
|
Karri |
|
Venn |
|
VP, Site Advocacy & Mentorship |
Society for Clinical Research Sites |
https://proventainternational.com/wp-content/uploads/2024/04/karri-venn.jpg |
Karri Venn brings over 25 years of clinical research experience working at clinical research sites. The ride has been monumental both in personal and professional growth. Ms. Venn started her career at LMC Healthcare in 1999 and that progressed to LMC Manna Research and ended with Centricity Research. A wide variety of positions Ms. Venn has held throughout the years in this wonderful organization and focused much of her role as a leader in operations growing the Canadian enterprise to one of the most successful integrated research organizations (IROs) in Canada. Always at the center of attention, was the importance to provide better healthcare to patients and has utilized the research experience as one way to achieve this goal. In maintaining this mission, Karri Venn has opened her own independent consulting company to further provide support to various organizations ie. Sponsor/CRO, Clinical Research Sites, Private Equity and is presently VP, Site Advocacy & Mentorship for SCRS (Society for Clinical Research Sites). Responsibilities throughout her tenure has included the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit and establishing the largest Canadian non-academic Endocrinology Research program. The merger and integration of various primary care and specialty clinical research sites to form one of the largest IROs in Canada. True North Research, Aventiv and IACT Health integrated with LMC Manna Research to form Centricity Research growing to more than 30 sites with expertise in all phases and majority of therapeutic areas. Additional responsibilities included acting as CEO for hyperCORE International a super network of elite sites coming together to share best practices and continue to push research excellence. Many distinctions and awards along the way include but not limited to: SPRIA, Centers of Excellence and Top 50 Great Places to Work for Canada. Ms. Venn has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator by ACRP. The importance of giving back and to share the site voice continues through her various consulting and strategic partnerships in the industry – most notably acting as chair of for the global committee of Society for Clinical Research Sites (SCRS). |
Princeton Marriott at Forrestal, Princeton, New Jersey 
Princeton Marriott at Forrestal, Princeton, New Jersey 
Payment Securely powered by stripe
